Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 45 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (22)
P 1 (3)
P 3 (1)

Trial Status

Recruiting17
Unknown15
Completed6
Enrolling By Invitation2
Not Yet Recruiting2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (45)

Showing 20 of 20 trials
NCT07377695Not ApplicableRecruitingPrimary

Remimazolam Consumption: TCI vs. Manual Infusion

NCT07517354RecruitingPrimary

Family-Based Moyamoya Susceptibility and Early Detection

NCT06714097Not ApplicableRecruiting

Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

NCT06724029Recruiting

Neurosurgical Outcome Network

NCT05491980Active Not Recruiting

Florida Cerebrovascular Disease Biorepository and Genomics Center

NCT07144930Not ApplicableRecruitingPrimary

Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments

NCT06477107Not ApplicableEnrolling By Invitation

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

NCT06634004Enrolling By InvitationPrimary

Biomarker-Led Optimization of Successful Surgical Outcomes in Moyamoya

NCT07304947Not ApplicableRecruitingPrimary

Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery

NCT07286110Phase 1Not Yet RecruitingPrimary

Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial

NCT07140731Not ApplicableRecruitingPrimary

The Symani Restore Study

NCT07065409Phase 1RecruitingPrimary

Treatment of Moyamoya Disease With iPSC-derived Exosomes

NCT05772572CompletedPrimary

Functional Disorders Moya Moya Young Patients

NCT01793168Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT06832839RecruitingPrimary

Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease

NCT06041659RecruitingPrimary

Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia

NCT06817434RecruitingPrimary

Study on Evaluating the Effectiveness of Statins in the Treatment of Moyamoya Disease

NCT05332756RecruitingPrimary

Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)

NCT06330818Not ApplicableRecruitingPrimary

Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients

NCT03546309Not ApplicableRecruitingPrimary

Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy

Scroll to load more

Research Network

Activity Timeline